| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Govt. & Public Relations | EVP, Govt and Public Relations
1 company
Daniel L Cohen last filed a Form 4 in May 2018, as EVP, Govt. & Public Relations at ZVRA. Daniel L Cohen's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,450 shares of ZVRA. Net of sales, the ZVRA filings show accumulation of 40,400 shares.
Daniel L Cohen has 9 Form 4 filings on record from September 2016 to May 2018, all as EVP, Govt. & Public Relations at Zevra Therapeutics (ZVRA), 2016–2018.
The 25 reported transactions were 20 open-market purchases, 3 gifts and 2 option or other derivative awards.
Counted by filing, the open-market trades come to 7 purchases worth about $179K and no sales.
The largest open-market purchase was 7,900 shares of ZVRA at an average $6.45 on May 15, 2018, about $51K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2018 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt. & Public Relations | Buy | 7,900 | $6.45 | $50,921.25 | -122.5% | |
| Nov 27, 2017 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt. & Public Relations | Buy | 7,500 | $3.79 | $28,422.75 | +30.0% | |
| Aug 24, 2017 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt. & Public Relations | Buy | 5,000 | $2.58 | $12,882.00 | +25.0% | |
| May 25, 2017 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt. & Public Relations | Buy | 2,500 | $4.11 | $10,273.62 | +14.3% | |
| Mar 31, 2017 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt. & Public Relations | Buy | 2,500 | $4.48 | $11,202.05 | +16.7% | |
| Nov 30, 2016 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt and Public Relations | Buy | 5,000 | $3.50 | $17,481.33 | +50.0% | |
| Sep 6, 2016 | ZVRA Zevra Therapeutics, Inc. | EVP, Govt and Public Relations | Buy | 10,000 | $4.75 | $47,470.86 | New |